Cel
Preventing immunological rejection of transplanted organs without the need for long-term use of pharmacological immunosuppression is a primary objective in transplantation medicine. Reducing the need for immunosuppression would dramatically improve the outcome for transplant recipients and reduce health costs for society. The means to achieve this goal has not been realised with pharmacological or biological agents yet. Conditioning the immune response of solid organ transplant recipients towards allograft acceptance using cell-based therapies is now becoming technically feasible and clinically promising. The central focus of our proposed cooperative work programme is to produce distinct populations of haematopoietic regulatory cells and comparatively test their safety and efficacy in minimising pharmacological immunosuppression in solid organ transplantation. Preparations of regulatory T cells, macrophages and dendritic cells will be licensed for clinical manufacture in outstanding research facilities across Europe, and subsequently, these different tolerance-promoting cell types will be assessed in a single Phase I/II clinical study for safety, clinical practicality and efficacy. The therapeutic potential of these cells will be directly compared using one, single clinical protocol. In addition, we will study the tolerogenic characteristics of these regulatory cell types at in-depth molecular and functional levels. These integrative, but very focused, research plans are expected to result in the identification of the most promising regulatory cell products for further testing, and commercial exploitation: the final outcome is to identify a cell product which has genuine potential to induce operational tolerance if correctly applied in a Phase IIb clinical trial. This objective can only be accomplished by the cooperation of the most experienced researchers in this field across Europe, in alliance with SMEs devoted to cell therapy.
Dziedzina nauki
Temat(-y)
Zaproszenie do składania wniosków
FP7-HEALTH-2010-single-stage
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-IP - Large-scale integrating projectKoordynator
93053 Regensburg
Niemcy
Zobacz na mapie
Uczestnicy (15)
WC2R 2LS London
Zobacz na mapie
OX1 2JD Oxford
Zobacz na mapie
10117 Berlin
Zobacz na mapie
20132 MILANO
Zobacz na mapie
44093 Nantes
Zobacz na mapie
51429 Bergish Gladbach
Zobacz na mapie
PE29 6XS Huntingdon
Zobacz na mapie
79108 FREIBURG
Zobacz na mapie
Zakończenie uczestnictwa
79100 FREIBURG IM BREISGAU
Zobacz na mapie
53100 Siena
Zobacz na mapie
53706 Madison Wi
Zobacz na mapie
LE11 3TU Loughborough
Zobacz na mapie
94607 OAKLAND CA
Zobacz na mapie
02114 Boston Ma
Zobacz na mapie
20132 Milano
Zobacz na mapie